Disease Initation and the role of DCs in the TRUC Model of ulcerative colitis

溃疡性结肠炎 TRUC 模型中疾病的发生和 DC 的作用

基本信息

  • 批准号:
    8038457
  • 负责人:
  • 金额:
    $ 12.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-03-01 至 2014-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): My interest in research dates back to high school when my father was diagnosed with pancreatic cancer. Lack of knowledge about and treatments for this disease led me to cancer research as an undergraduate. During my MD/PhD training, my interests broadened to encompass cell biology and immunology. These interests shaped my decision to pursue a residency in internal medicine and fellowship in oncology. During my fellowship in Dr. Laurie Glimcher's laboratory at the Harvard School of Public Health, I am studying the immunology of and role of commensal microbes in inflammatory bowel disease. My post-doctoral training will prepare me to direct a laboratory that studies the function of inflammation and microbes in colon cancer. We have developed a mouse model of ulcerative colitis (UC) that resembles the human disease. Loss of T-bet in the innate immune system results in spontaneous and communicable UC, in the absence of adaptive immunity (termed TRUC) and increased susceptibility to colitis in immunologically intact hosts. I propose to 1 ) determine whether dendritic cells (DCs) are necessary for TRUC colitis and the factors recruiting DCs to TRUC colons 2) probe the role of the epithelial barrier and the microbiota in TRUC and 3) determine the bacterial-derived signals activating DCs in TRUC. Aim 1 will focus on the role of T-bet and colonic DCs and employs transgenic approaches to prove that the DC is the effector cell necessary and sufficient for colitis in TRUC. Employing both cell biological and microbiological approaches, I will thoroughly interrogate the epithelial barrier and key, pro-inflammatory microbes in this colitis. Using both bacterial derived products and mouse models, I will seek to determine the bacterial derived signals activating DCs in TRUC colitis. RELEVANCE: Inflammatory bowel diseases are devastating illnesses that cause significant morbidity and mortality. We have generated a mouse model of ulcerative colitis that bears a great resemblance to the human disease. Studies of this model will hopefully lead to the identification of new therapies for patients with these diseases.
描述(由申请人提供):我对研究的兴趣可以追溯到高中时期,当时我父亲被诊断出患有胰腺癌。由于缺乏对这种疾病的了解和治疗方法,我在本科时开始了癌症研究。在我的医学博士/博士培训期间,我的兴趣扩展到细胞生物学和免疫学。这些兴趣塑造了我追求内科住院医师和肿瘤学奖学金的决定。在哈佛大学公共卫生学院劳里·格里姆彻博士的实验室学习期间,我正在研究共生微生物在炎症性肠病中的免疫学和作用。我的博士后训练将为我指导一个研究炎症和微生物在结肠癌中的作用的实验室做准备。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wendy S. Garrett其他文献

Immune recognition of microbial metabolites
微生物代谢物的免疫识别
  • DOI:
    10.1038/s41577-019-0252-2
  • 发表时间:
    2019-11-25
  • 期刊:
  • 影响因子:
    60.900
  • 作者:
    Wendy S. Garrett
  • 通讯作者:
    Wendy S. Garrett
Bacteria in cancer initiation, promotion and progression
癌症发生、促进和进展中的细菌
  • DOI:
    10.1038/s41568-023-00594-2
  • 发表时间:
    2023-07-03
  • 期刊:
  • 影响因子:
    66.800
  • 作者:
    Geniver El Tekle;Wendy S. Garrett
  • 通讯作者:
    Wendy S. Garrett
The metabolic sensor LKB1 regulates ILC3 homeostasis and mitochondrial function
代谢传感器 LKB1 调节 ILC3 稳态和线粒体功能
  • DOI:
    10.1016/j.celrep.2025.115456
  • 发表时间:
    2025-04-22
  • 期刊:
  • 影响因子:
    6.900
  • 作者:
    Diogo Fonseca-Pereira;Sena Bae;Slater L. Clay;Monia Michaud;Meghan H. MacDonald;Jonathan N. Glickman;Wendy S. Garrett
  • 通讯作者:
    Wendy S. Garrett
Microbiota organization—a key to understanding CRC development
微生物群结构——理解 CRC 发展的关键
Engineered emEscherichia coli/em for the emin situ/em secretion of therapeutic nanobodies in the gut
用于肠道中治疗性纳米抗体原位分泌的工程化大肠杆菌
  • DOI:
    10.1016/j.chom.2023.03.007
  • 发表时间:
    2023-04-12
  • 期刊:
  • 影响因子:
    18.700
  • 作者:
    Jason P. Lynch;Coral González-Prieto;Analise Z. Reeves;Sena Bae;Urmila Powale;Neha P. Godbole;Jacqueline M. Tremblay;Florian I. Schmidt;Hidde L. Ploegh;Vikram Kansra;Jonathan N. Glickman;John M. Leong;Charles B. Shoemaker;Wendy S. Garrett;Cammie F. Lesser
  • 通讯作者:
    Cammie F. Lesser

Wendy S. Garrett的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wendy S. Garrett', 18)}}的其他基金

Designer Probiotics for the treatment of intestinal infection and inflammation
用于治疗肠道感染和炎症的设计师益生菌
  • 批准号:
    9356497
  • 财政年份:
    2016
  • 资助金额:
    $ 12.52万
  • 项目类别:
Designer Probiotics for the treatment of intestinal infection and inflammation
用于治疗肠道感染和炎症的设计师益生菌
  • 批准号:
    9769017
  • 财政年份:
    2016
  • 资助金额:
    $ 12.52万
  • 项目类别:
Designer Probiotics for the treatment of intestinal infection and inflammation
用于治疗肠道感染和炎症的设计师益生菌
  • 批准号:
    10004029
  • 财政年份:
    2016
  • 资助金额:
    $ 12.52万
  • 项目类别:
Gut microbiota and inflammatory monocytes in colorectal cancer
结直肠癌中的肠道微生物群和炎症单核细胞
  • 批准号:
    8816042
  • 财政年份:
    2011
  • 资助金额:
    $ 12.52万
  • 项目类别:
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
结直肠癌发生和具核梭杆菌:致癌微生物、致癌代谢物和肿瘤免疫学
  • 批准号:
    9977924
  • 财政年份:
    2011
  • 资助金额:
    $ 12.52万
  • 项目类别:
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
结直肠癌发生和具核梭杆菌:致癌微生物、致癌代谢物和肿瘤免疫学
  • 批准号:
    10665786
  • 财政年份:
    2011
  • 资助金额:
    $ 12.52万
  • 项目类别:
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
结直肠癌发生和具核梭杆菌:致癌微生物、致癌代谢物和肿瘤免疫学
  • 批准号:
    10207518
  • 财政年份:
    2011
  • 资助金额:
    $ 12.52万
  • 项目类别:
Gut microbiota and inflammatory monocytes in colorectal cancer
结直肠癌中的肠道微生物群和炎症单核细胞
  • 批准号:
    8444653
  • 财政年份:
    2011
  • 资助金额:
    $ 12.52万
  • 项目类别:
Gut microbiota and inflammatory monocytes in colorectal cancer
结直肠癌中的肠道微生物群和炎症单核细胞
  • 批准号:
    8607163
  • 财政年份:
    2011
  • 资助金额:
    $ 12.52万
  • 项目类别:
Colorectal carcinogenesis and Fusobacterium nucleatum: oncomicrobe, oncometabolites, and oncoimmunology
结直肠癌发生和具核梭杆菌:致癌微生物、致癌代谢物和肿瘤免疫学
  • 批准号:
    9307232
  • 财政年份:
    2011
  • 资助金额:
    $ 12.52万
  • 项目类别:

相似国自然基金

基于Teach-back药学科普模式的慢阻肺患者吸入用药依从性及疗效研究
  • 批准号:
    2024KP61
  • 批准年份:
    2024
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Quench-Back保护的超导螺线管磁体失超过程数值模拟研究
  • 批准号:
    51307073
  • 批准年份:
    2013
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
  • 批准号:
    2338816
  • 财政年份:
    2024
  • 资助金额:
    $ 12.52万
  • 项目类别:
    Continuing Grant
One-step reconstruction of plastic waste back to its constituent monomers (ONESTEP)
将塑料废物一步重建回其组成单体(ONESTEP)
  • 批准号:
    EP/Y003934/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.52万
  • 项目类别:
    Research Grant
On the origin of very massive back holes
关于巨大背洞的起源
  • 批准号:
    DP240101786
  • 财政年份:
    2024
  • 资助金额:
    $ 12.52万
  • 项目类别:
    Discovery Projects
Back to our roots: Re-activating Indigenous biocultural conservation
回到我们的根源:重新激活本土生物文化保护
  • 批准号:
    FT230100595
  • 财政年份:
    2024
  • 资助金额:
    $ 12.52万
  • 项目类别:
    ARC Future Fellowships
Collaborative Research: FuSe: Indium selenides based back end of line neuromorphic accelerators
合作研究:FuSe:基于硒化铟的后端神经形态加速器
  • 批准号:
    2328741
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
    Continuing Grant
Collaborative Research: NSFGEO-NERC: MEZCAL: Methods for Extending the horiZontal Coverage of the Amoc Latitudinally and back in time (MEZCAL)
合作研究:NSFGEO-NERC:MEZCAL:扩展 Amoc 纬度和时间回水平覆盖范围的方法 (MEZCAL)
  • 批准号:
    2409764
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
    Standard Grant
Relationships Between Pain-Related Psychological Factors, Gait Quality, and Attention in Chronic Low Back Pain
慢性腰痛中疼痛相关心理因素、步态质量和注意力之间的关系
  • 批准号:
    10679189
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
The Role of VEGF in the Development of Low Back Pain Following IVD Injury
VEGF 在 IVD 损伤后腰痛发展中的作用
  • 批准号:
    10668079
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
Psilocybin and Affective Function in Chronic Lower Back Pain and Depression
裸盖菇素与慢性腰痛和抑郁症的情感功能
  • 批准号:
    10626449
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
Brain Mechanisms of Chronic Low-Back Pain: Specificity and Effects of Aging and Sex
慢性腰痛的脑机制:衰老和性别的特异性和影响
  • 批准号:
    10657958
  • 财政年份:
    2023
  • 资助金额:
    $ 12.52万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了